Fayetteville, Arkansas — Fayetteville, Arkansas

Fayetteville, Arkansas is a clinical research site located in Fayetteville, Arkansas, United States 72703.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Fayetteville, Arkansas has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Alopecia Areata, Diabetic Macular Edema (DME).

Sponsors: Q32 Bio Inc., EyeBiotech Ltd..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fayetteville, Arkansas?

Fayetteville, Arkansas has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fayetteville, Arkansas conducted?

Fayetteville, Arkansas has 2 clinical trials on record, with 2 currently active. Their work covers Alopecia Areata, Diabetic Macular Edema (DME).

Is Fayetteville, Arkansas accredited by Crixeo Health?

Fayetteville, Arkansas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fayetteville, Arkansas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.